ZURICH, Aug 11 (Reuters) - Australia’s drugs regulator banned the use of Novartis’s (NOVN.VX: Quote, Profile, Research) Prexige because of liver problems in patients using the painkiller, the watchdog said, including two deaths and two liver transplants.
